Relative Age and Attention-Deficit/Hyperactivity Disorder: Data From Three Epidemiological Cohorts and a Meta-analysis.


Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
08 2020
Historique:
received: 04 03 2019
revised: 10 07 2019
accepted: 25 07 2019
pubmed: 24 8 2019
medline: 19 3 2021
entrez: 24 8 2019
Statut: ppublish

Résumé

To investigate the effect of relatively younger age on attention-deficit/hyperactivity disorder (ADHD) symptoms and diagnosis through three population-based cohorts and a meta-analysis. This study included participants of three community-based cohorts in Brazil: 1993 Pelotas Cohort (N = 5,249), 2004 Pelotas Cohort (N = 4,231), and Brazilian High-Risk Study for Psychiatric Disorders (HRC study) (N = 2,511). We analyzed the effect of relatively younger age on ADHD symptoms and diagnosis. For the meta-analysis, we searched MEDLINE, PsycINFO, and Web of Science from inception through December 25, 2018. We selected studies that reported measures of association between relative immaturity and an ADHD diagnosis. We followed the Meta-analysis Of Observational Studies in Epidemiology guidelines. The protocol for meta-analysis is available on PROSPERO (CRD42018099966). In the meta-analysis, we identified 1,799 potentially eligible records, from which 25 studies including 8,076,570 subjects (164,049 ADHD cases) were analyzed with their effect estimates. The summarized relative risk of an ADHD diagnosis was 1.34 (95% CI, 1.26-1.43, p < .001) for children born in the first 4 months of the school year (relatively younger). Heterogeneity was high (I Children and adolescents who are relatively younger compared with their classmates have a higher risk of receiving an ADHD diagnosis. Clinicians should consider the developmental level of young children when evaluating ADHD symptoms.

Identifiants

pubmed: 31442562
pii: S0890-8567(19)31432-7
doi: 10.1016/j.jaac.2019.07.939
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

990-997

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Arthur Caye (A)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil.

Sandra Petresco (S)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Aluísio Jardim Dornellas de Barros (AJD)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil.

Rodrigo A Bressan (RA)

National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil.

Ary Gadelha (A)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil.

Helen Gonçalves (H)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil.

Arthur Gus Manfro (AG)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil.

Alícia Matijasevich (A)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil; Faculty of Medicine FMUSP, University of São Paulo, São Paulo, Brazil.

Ana Maria Baptista Menezes (AMB)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil.

Euripides C Miguel (EC)

National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil.

Tiago Neuenfeld Munhoz (TN)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil.

Pedro M Pan (PM)

National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil.

Giovanni A Salum (GA)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil.

Iná S Santos (IS)

Postgraduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil.

Christian Kieling (C)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Luis Augusto Rohde (LA)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil. Electronic address: lrohde@terra.com.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH